EyePoint Pharmaceuticals, Inc. (EYPT): Price and Financial Metrics

EyePoint Pharmaceuticals, Inc. (EYPT)

Today's Latest Price: $0.87 USD

0.01 (1.10%)

Updated Jun 1 9:40am

Add EYPT to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 214 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

EYPT Stock Summary

  • As for revenue growth, note that EYPT's revenue has grown 356.96% over the past 12 months; that beats the revenue growth of 98.1% of US companies in our set.
  • In terms of volatility of its share price, EYPT is more volatile than 81.09% of stocks we're observing.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for EYPT comes in at -53.87% -- higher than that of just 8.4% of stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to EyePoint Pharmaceuticals Inc are PAR, PLT, RWLK, AVGR, and GIGA.
  • Visit EYPT's SEC page to see the company's official filings. To visit the company's web site, go to eyepointpharma.com.
EYPT Daily Price Range
EYPT 52-Week Price Range

EYPT Stock Price Chart More Charts

EYPT Price/Volume Stats

Current price $0.87 52-week high $2.69
Prev. close $0.86 52-week low $0.70
Day low $0.86 Volume 26,445
Day high $0.88 Avg. volume 664,453
50-day MA $0.89 Dividend yield N/A
200-day MA $1.48 Market Cap 108.46M

EyePoint Pharmaceuticals, Inc. (EYPT) Company Bio

EyePoint Pharmaceuticals (formerly pSivida Corp.) develops sustained-release drug-delivery products for treating eye diseases in the United States and the United Kingdom. It offers ILUVIEN, an injectable, sustained-release micro-insert for use in treating vision impairment associated with diabetic macular edema; and Retisert for the treatment of posterior uveitis. The company was founded in 1987 and is based in Watertown, Massachusetts.

EYPT Latest News Stream

Event/TimeNews Detail
Loading, please wait...

EYPT Latest Social Stream

Loading social stream, please wait...

View Full EYPT Social Stream

Latest EYPT News From Around the Web

Below are the latest news stories about EyePoint Pharmaceuticals Inc that investors may wish to consider to help them evaluate EYPT as an investment opportunity.

Should You Buy EyePoint Pharmaceuticals, Inc. (EYPT)?

At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW). In these volatile markets we scrutinize hedge fund filings to get a reading on which direction each […]

Yahoo | May 27, 2020

EyePoint Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference

WATERTOWN, Mass., May 26, 2020 -- EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a pharmaceutical company committed to developing and commercializing innovative ophthalmic.

Yahoo | May 26, 2020

Edited Transcript of EYPT earnings conference call or presentation 6-May-20 12:30pm GMT

Q1 2020 EyePoint Pharmaceuticals Inc Earnings Call

Yahoo | May 25, 2020

EyePoint Pharmaceuticals Presents Data Showcasing DEXYCU® at the American Society of Cataract and Refractive Surgery 2020 Virtual Annual Meeting

WATERTOWN, Mass., May 18, 2020 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and…

GlobeNewswire | May 18, 2020

EyePoint Pharmaceuticals Reports First Quarter 2020 Financial Results and Highlights Recent Corporate Developments

- Total revenues of $7.5 million and net product revenues of $4.7 million - - Cash conservation and reorganization initiatives coupled…

GlobeNewswire | May 6, 2020

Read More 'EYPT' Stories Here

EYPT Price Returns

1-mo -7.75%
3-mo -36.96%
6-mo -43.51%
1-year -44.59%
3-year -61.33%
5-year -77.69%
YTD -43.87%
2019 -17.99%
2018 75.00%
2017 -36.84%
2016 -64.52%
2015 17.27%

Continue Researching EYPT

Here are a few links from around the web to help you further your research on EyePoint Pharmaceuticals Inc's stock as an investment opportunity:

EyePoint Pharmaceuticals Inc (EYPT) Stock Price | Nasdaq
EyePoint Pharmaceuticals Inc (EYPT) Stock Quote, History and News - Yahoo Finance
EyePoint Pharmaceuticals Inc (EYPT) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.8038 seconds.